Naturally Occurring Anti-i/I Cold Agglutinins May Be Encoded by Different VH3 Genes As Well As the VH4.21 Gene Segment
Overview
Authors
Affiliations
In the current study, we wished to determine if the V regions encoding the naturally occurring anti-i/I Cold Agglutinins (anti-i/I CA) differ from pathogenic anti-i/I CA that are exclusively encoded by the VH4.21 gene. After EBV transformation of B lymphocytes, we generated one anti-I secreting clone from each of two individuals; clone 4G (individual CM, PBL) and clone Sp1 (individual SC, spleen). Clone 4G expresses a VH3 gene sequence that is 92% homologous to the germline gene WHG26. Clone Sp1 also expresses a VH3 gene that is 98% homologous to the fetally rearranged M85/20P1 gene. Another clone, Sp2 (anti-i specificity), from individual SC is 98% homologous to the germline gene VH4.21. For correlation, we studied anti-i/I CA fractions purified from 15 normal sera and found no or relatively small amounts of 9G4 (VH4.21 related idiotype) reactive IgM. Five cold agglutinin fractions contained large amounts of VH3-encoded IgM (compared to pooled normal IgM) by virtue of their binding to modified protein Staph A (SPA), and absorption of three CA fractions with modified SPA specifically removed anti-i/I binding specificity entirely. Collectively, the data indicate that naturally occurring anti-i/I CA may be encoded to a large extent by non-VH4.21-related genes, and that the VH4.21 gene is not uniquely required for anti-i/I specificity.
Zhou P, Mansukhani M, Yeh R, Lu J, Xia H, Koganti L Br J Cancer Res. 2025; 7(2):681-686.
PMID: 39790465 PMC: 11711923. DOI: 10.31488/bjcr.193.
Autoimmune Cytopenias in Chronic Lymphocytic Leukemia: Focus on Molecular Aspects.
Fattizzo B, Barcellini W Front Oncol. 2020; 9:1435.
PMID: 31998632 PMC: 6967408. DOI: 10.3389/fonc.2019.01435.
Malecka A, Troen G, Tierens A, Ostlie I, Malecki J, Randen U Haematologica. 2016; 101(9):e361-4.
PMID: 27198717 PMC: 5060031. DOI: 10.3324/haematol.2016.146126.
Primary chronic cold agglutinin disease: an update on pathogenesis, clinical features and therapy.
Berentsen S, Beiske K, Tjonnfjord G Hematology. 2007; 12(5):361-70.
PMID: 17891600 PMC: 2409172. DOI: 10.1080/10245330701445392.
Thorpe S, Turner C, Stevenson F, Spellerberg M, Thorpe R, Natvig J Immunology. 1998; 93(1):129-36.
PMID: 9536129 PMC: 1364116. DOI: 10.1046/j.1365-2567.1998.00406.x.